LifeMDLFMD
LFMD
0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
63% more call options, than puts
Call options by funds: $775K | Put options by funds: $476K
50% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 26
47% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 15
6% more funds holding
Funds holding: 100 [Q3] → 106 (+6) [Q4]
2.98% less ownership
Funds ownership: 40.03% [Q3] → 37.05% (-2.98%) [Q4]
12% less capital invested
Capital invested by funds: $90.4M [Q3] → $79.4M (-$11M) [Q4]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$7
29%
upside
Avg. target
$12
121%
upside
High target
$15
176%
upside
3 analyst ratings
3 positive
100%
0 neutral
0%
0 negative
0%
HC Wainwright & Co. Yi Chen 38% 1-year accuracy 63 / 167 met price target | 158%upside $14 | Buy Maintained | 12 Mar 2025 |
Cantor Fitzgerald Sarah James 35% 1-year accuracy 39 / 113 met price target | 176%upside $15 | Overweight Reiterated | 11 Mar 2025 |
Keybanc Scott Schoenhaus 26% 1-year accuracy 8 / 31 met price target | 29%upside $7 | Overweight Maintained | 8 Jan 2025 |
Financial journalist opinion
Based on 7 articles about LFMD published over the past 30 days
Neutral
GlobeNewsWire
1 day ago
LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the 24th Annual Needham Virtual Healthcare Conference taking place April 7-10, 2025. Management will be presenting a corporate overview and will be holding one-on-one meetings with investors.

Neutral
GlobeNewsWire
1 week ago
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on April 15, 2025, to holders of record at the close of business on April 4, 2025.

Neutral
Seeking Alpha
3 weeks ago
LifeMD, Inc. (LFMD) Q4 2024 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD ) Q4 2024 Results Conference Call March 10, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman and Chief Executive Officer Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG Steve Dechert - KeyBanc Brooks O'Neil - Lake Street Capital Markets Steven Valiquette - Mizuho Securities Alex Fuhrman - Craig-Hallum Capital Group Sarah James - Cantor Anderson Schock - B. Riley Securities Operator Good afternoon.

Neutral
GlobeNewsWire
3 weeks ago
LifeMD Reports Fourth Quarter 2024 Results
Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60% Adjusted EBITDA increased 78% to $9.0 million Telehealth adjusted EBITDA increased 396% to $5.9 million Full-year cash flow from operations increased 99% to $17.5 million and generated positive full-year net cash flow Exited 2024 with over $35 million in cash Introduces 2025 guidance for consolidated revenue of $265 million to $275 million and consolidated adjusted EBITDA of $30 million to $32 million Conference call begins at 4:30 p.m. Eastern time today NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today reported financial results for the three and 12 months ended December 31, 2024.

Positive
Reuters
3 weeks ago
Telehealth firms Teladoc, LifeMD tie up with Eli Lilly's pharmacy partner to offer Zepbound
Telehealth firms Teladoc Health and LifeMD said on Thursday they have signed an agreement with Eli Lilly's direct-to-consumer website LillyDirect pharmacy partner, Gifthealth, to offer patients the weight-loss drug, Zepbound.

Neutral
GlobeNewsWire
3 weeks ago
LifeMD® Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound
NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced it is integrating with LillyDirect pharmacy provider, Gifthealth, to offer streamlined access of single-dose vials of Lilly's prescription obesity treatment Zepbound® (tirzepatide) to eligible LifeMD patients. Integration with the LillyDirect ® self-pay pharmacy channel will provide a seamless solution to a patient's Zepbound fulfillment journey while continuing to offer more accessible pricing and direct shipment to patients.

Neutral
GlobeNewsWire
3 weeks ago
LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum
NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the KeyBanc Capital Markets Healthcare Forum being held virtually on March 18-19, 2025. Management will participate in a fireside chat on Tuesday, March 18th at 11:15 a.m. Eastern time and will hold one-on-one meetings throughout the conference.

Neutral
GlobeNewsWire
1 month ago
LifeMD to Report Fourth Quarter 2024 Financial Results on March 10
NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2024 after the close of the U.S. financial markets on March 10, 2025 and will host a conference call beginning at 4:30 p.m. Eastern time.

Neutral
GlobeNewsWire
1 month ago
LifeMD® Announces Entry Into the Behavioral Health Market
Expansion to Include Teletherapy, Psychiatry and Medication Management Behavioral Health Offering to be Led by Industry Veteran Julian Cohen NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its expansion into the behavioral health market. This strategic move broadens LifeMD's service offerings to include teletherapy, psychiatry and medication management for common mental health conditions.

Neutral
GlobeNewsWire
2 months ago
LifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held February 11-12, 2025, at the Cliff Lodge in Snowbird, Utah. Management will hold one-on-one meetings throughout the conference.

Charts implemented using Lightweight Charts™